Trials / Unknown
UnknownNCT03421015
Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic Evolution
Genomic Analysis in Localized or Locally Advanced Prostate Cancer. Identification of Biomarkers Predictive of Biochemical or Metastatic Recurrence
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 84 (estimated)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Developing a genetic study on localized or locally advanced prostate cancer. The aim of the study is to identify genomic alteration predictive of metastatic recurrence in the context of primary heterogeneity, by using the next generation sequencing (NGS) techniques. Identifying such biomarkers may be useful to detect a higher relapse risk, and thus lower the mortality rate.
Conditions
Timeline
- Start date
- 2017-05-01
- Primary completion
- 2020-07-01
- Completion
- 2020-07-01
- First posted
- 2018-02-05
- Last updated
- 2019-11-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03421015. Inclusion in this directory is not an endorsement.